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ABSTRACT  
Introduction: Complications due to diabetes are a major cause of disability, reduced quality of life and death. Recent studies have 
emphasized the role of serum ferritin in insulin resistance and the incidence of diabetes mellitus. However, the role of ferritin as a marker 
of iron overload in pancreatic damage and peripheral insulin resistance or its role as an inflammatory marker is not clear. The aim of this 
study is to establish a correlation between serum ferritin, FBS and HbA1c in type 2 diabetes mellitus and to evaluate the role of serum 
ferritin on the glycemic status in type 2 diabetes mellitus. Methods: This was a cross- sectional study of 100 cases, visiting medical 
outpatient department of a tertiary care teaching hospital. Diabetic patients were compared with age and sex matched normal healthy 
controls. Effect of serum ferritin on glycemic status, gender and age was noted. Results: Statistically significant increase of FPG, HbA1C 
and serum ferritin levels were observed in type 2 diabetes mellitus group than controls in both females and males while there was no 
statistically significant difference of hemoglobin between diabetic group and controls in females and males. There was a high (r= 0.62, r= 
0.66) positive correlation between SF and HbA1c of females and males respectively in diabetic group P-value=< 0.01. Conclusion: Higher 
positive correlation of serum ferritin with HbA1c shows that hyperglycemia affects ferritin levels possibly due to inflammation or 
oxidative stress or a combination of the two. 
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INTRODUCTION 
Diabetes is a metabolic disorder characterized by hyperglycemia 
resulting from defects in insulin secretion, insulin action, or 
both[1]. Diabetes has become a major public health concern both 
in developing and developed countries worldwide affecting 382 
million people aged between 40 and 59 years and 80% of them 
live in low and middle income countries. It is expected to rise to 
592 million by the year 2035 [2]. 
Diabetes imposes a large economic burden on individuals and 
families, national health systems and countries. Health spending 
on diabetes accounted for 10.8% of total health expenditure 
worldwide [3]. 
People with type-2 diabetes mellitus develop characteristic 
microvascular complications such as retinopathy, nephropathy 
and neuropathy. There is also increased risk of macrovascular 
complications such as cardiovascular, cerebrovascular and 
peripheral vascular disease [4]. 
Complications due to diabetes are a major cause of disability, 
reduced quality of life and death. Approximately 5.1 million 
people aged between 20 and 79 years died from diabetes 
accounting for 8.4% of global all cause mortality in this age 
group [5]. In India 65.1 million in the age group of 20 and 79 have 
diabetes (8.56%) and expected to rise to 109 million by the year 
2035[2]. 
The pathogenesis of type 2 diabetes mellitus (T2DM) is 
complex and involves the interaction of genetic and 
environmental factors. Individuals with T2DM show both 
insulin resistance and beta cell defects [6]. Type 2 diabetes is 
largely preventable. A number of risk factors, such as 
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overweight and obesity and physical inactivity are modifiable, 
and can also help reduce the complications that are associated 
with diabetes. But in most countries, the prevalence of 
overweight and obesity continues to increase [7]. 
Hyperglycemia in diabetes mellitus not only defines the disease 
but is the cause of its most characteristic symptoms and long-
term complications. The complications of diabetes mellitus are 
influenced not only by the duration of the diabetes mellitus but 
also by the average level of blood glucose along with glycated 
haemoglobin [4]. 
Serum ferritin is an acute phase reactant, and is a marker of iron 
stores in the body [8] Iron is a transitional metal that can easily 
become oxidized and thus act as an oxidant [9]. Increased 
accumulation of iron affects insulin synthesis and secretion in 
the pancreas and liver. 
Recent studies have shown that serum ferritin was proportional 
to serum glucose concentration, diastolic blood pressure, HDL 
cholesterol, and insulin resistance. In fact, the higher the ferritin 
levels, the higher the incidence of type-2 diabetes [10, 11]. 
Amongst the various markers of glycemic control, glycated 
hemoglobin has now been established as the most reliable. 
However, ferritin’s role as a marker of iron overload in 
pancreatic damage and peripheral insulin resistance or its role as 
an inflammatory marker is not clear. Hence this study aims to 
examine the relationship between serum ferritin and HbA1c 
levels in type-2 diabetes mellitus [12]. 
MATERIALS AND METHODS 
This was a cross- sectional study of 100 cases, visiting medical 
outpatients department of Dr. PSIMS and RF, Gannavaram. The 
study was approved by the institutional ethical committee. 50 
diabetic patients were compared with 50 age and sex matched 
normal healthy controls. The cases were randomly recruited. 
After taking a signed informed consent, all cases were subjected 
to a detailed questionnaire which included age of onset, duration 
of diabetes, treatment modalities, family history of diabetes and 
associated risk factors. 
The selection criteria was based on patients having haemoglobin 
level of more than or equal to 10g/dl, known cases of type-2 
diabetes mellitus (M/F) in the age group of 35-65 years and 
cases with duration of diabetes of 2-10 years were included in 
the study. 
Diabetics with history or evidence of conditions leading to iron 
loss like gastro-intestinal blood loss, history of blood transfusion 
or donation in the last one year, subjects with type 1 diabetes 
mellitus, gestational diabetes mellitus, hemochromatosis, 
thalassemia, hemosiderosis, on iron supplementation, thiazide 
diuretics, antioxidants drugs, steroids, subjects with chronic 
infections, neoplastic condition, renal disease, liver disease, 
alcoholics, smokers, critically ill patients admitted in intensive 
care unit were all excluded from the study. 
 The serum ferritin, HbA1c, FPG, and hemoglobin percentage 
were estimated in 50 normal healthy individuals (control group) 
and 50 cases of type-2 diabetes mellitus (diabetic group). Both 
controls and cases were grouped based on their gender. There 
were 24 and 26 numbers of female and male controls and 25 
numbers each of female and male cases. 
The subjects were asked to fast for a period of at least 8hrs. 5ml 
of venous blood was drawn from each person. Samples were 
used for the measurement of the plasma glucose by glucose 
oxidase method, HbA1c by latex agglutination inhibition assay 
by Randox Daytona autoanalyzer and serum ferritin by 
chemilumescence method by Lumax Monobind analyzer. Blood 
hemoglobin was estimated using spectrophotometer by 
cyanmethaemoglobin method. Hemolysed samples were 
discarded and all reagents used were brought to at room 
temperature before analysis. 
STATISTICAL ANALYSIS 
Statistical analysis was done using SPSS software (Graph pad 
Prism 6). Statistical analysis of the following parameters, serum 
ferritin(SF), glycated hemoglobin (HbA1c), fasting plasma 
glucose (FPG) and hemoglobin percentage (Hb %) were done 
by t – test using graph pad (prism 6). Interpretation was based 
on comparison between controls and diabetic group and 
according to age and gender. Unpaired t-test was used for 
quantitative variables and Pearson’s correlation coefficient for 
comparison of other variables. A P-value of <0.05 was 
considered significant and >0.05 as non-significant. 
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RESULTS 
The mean age of the controls in years are 40.41 ± 5.50 and 40.73 
±8.16 in females and males respectively. The mean age of the 
cases in years are 41.2 ± 8.06 and 43.32 ± 8.35 in females and 
males respectively. There was no statistical significant 
difference of age between the two groups in either gender. 
The mean FPG, HbA1c and serum ferritin levels were increased 
in diabetic group compared to controls while hemoglobin levels 
were decreased in diabetic group. There is statistically 
significant difference between FPG, HbA1c and serum ferritin 
of diabetic and controls and no statistically significant 
difference of hemoglobin levels between the two groups [Table 
1]. 
Table 1. Comparison of parameters in control & diabetic 
groups 
 
The mean fasting plasma glucose levels, HbA1c levels, serum 
ferritin levels were more in diabetic group compared to controls 
in both females and males, while hemoglobin levels was more 
or less equal in both in diabetic and control groups [Table 2]. 
Table 2. FPG, HbA1c, Serum Ferritin and Hb in control 
and diabetic groups 
Males had higher serum ferritin levels compared to females both 
in diabetic and control groups.  A small variation of mean 
HbA1c levels was observed between males and females in both 
diabetic and controls. Mean fasting plasma glucose levels were 
higher in males than females. A small variation in Hemoglobin 
levels was seen on comparison of males and females [Table 2]. 
Statistically significant increase of FPG, HbA1C and serum 
ferritin levels were observed in cases of type 2 diabetes mellitus 
than controls in both females and males while there was no 
statistically significant difference of hemoglobin between 
diabetic and controls in females and males. [Table 3]. 
Table 3. p - value (comparison between control & diabetic 
groups) 
Gender HbA1c SF FPG Hb 
Male <0.05 <0.05 <0.05 >0.05 
Female <0.05 <0.05 <0.05 >0.05 
Comparison of serum ferritin was done with HbA1c, FPG and 
age in both genders. 
There was a moderate (r= 0.50, r = 0.54) positive correlation 
between SF and HbA1c of females and males respectively in 
controls, p-value =< 0.05 in both [Figure 1]. There was a high 
(r= 0.62, r= 0.66) positive correlation between SF and HbA1c of 
females and males respectively in diabetic group, p-
value=<0.01 in both [Figure 1]. 
There was a low (r = 0.37, r = 0.43) positive correlation between 
SF and FPG of females and males respectively in controls p-
value=>0.05 in both [Figure-2].There was a moderate (r=0.51 
r= 0.46) positive correlation between SF and FPG of females 
and males respectively in diabetic group, p-value=<0.01[Figure 
2]. There was a low (r = 0.2, r= 0.19) positive correlation 
between SF and age of females and males respectively in 
controls, p-value =>0.05 in both [Figure 3]. There was a low (r 
= 0.28, r= 0.10) positive correlation between SF and age of 
females and males respectively in diabetic group, p-value 
=>0.05 in both [Figure 3] 
DISCUSSION  
Parameters Controls Diabetic P value 
FPG (mg/dl) 85.48 ± 12.08 182.26 ± 54.42 <0.05 
HbA1c (%) 4.46 ± 0.60 7.15 ± 0.98 <0.05 
Serum Ferritin 
(μg/l) 
16.71 ± 6.27 134.37 ± 65.79 <0.05 
Hb (g/dl) 11.79 ± 0.93 11.49 ± 1.18 >0.05 
Diabetic / 
Control by 
gender 
FPG 
(mg/dl) 
HbA1c 
(%) 
SF 
(μg/l) 
Hb 
(g/dl) 
Mean ± 
SD 
Mean ± 
SD 
Mean ± 
SD 
Mean ± 
SD 
Female 
(controls) 
82 ± 
12.53 
4.36 ± 
0.65 
14.79 ± 
6.09 
11.3 ± 
0.81 
Female 
(Diabetic) 
157.4 ± 
52.22 
6.75 ± 
0.95 
96.95 ± 
46.66 
10.86 ± 
1.09 
Male 
(controls) 
88.69 ± 
10.92 
4.56 ± 
0.55 
18.49 ± 
6.02 
12.25 ± 
0.82 
Male 
(Diabetic) 
207.12 ± 
45.09 
7.56 ± 
0.87 
171.80 
± 61.18 
12.13 ± 
0.91 
Type 2 diabetes mellitus (DM) is a chronic metabolic disorder 
and its prevalence has been increasing steadily all over the 
world. People living   with   type 2 DM are   more  vulnerable to     
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i) r= 0.50                                             ii) r = 0.54 
 
      iii)   r= 0.62                                                         iv) r= 0.66 
Figure 1. Relation between SF & HbA1c of females and males in control and diabetic groups (cases) 
 
i) r = 0.37      ii) r = 0.43 
 
iii) r=0.51     iv) r= 0.46 
Figure 2. Relation between SF & FPG of females and males in control and diabetic groups (cases)
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i) r = 0.2                                                               ii) r =  0.19 
 
iii) r = 0.28                           iv) r= 0.10 
Figure 3. Relation between SF & Age of females and males in control and diabetic groups (cases)
various forms of both short- and long- term complications, 
which often lead to their premature death. 
Oxidative stress has been implicated in the pathogenesis of the 
complications seen in type 2 DM [13]. “Oxidative stress", is 
defined as the oxidation of cellular components thereby 
introducing/producing harm to that cellular tissue. Oxidation 
reactions ensure that molecular oxygen is completely reduced to 
water, but the products of partial reduction of oxygen are highly 
reactive and create havoc in the living systems. Hence, they are 
also called reactive oxygen species (ROS) [14]. 
Oxygen normally accepts four electrons and is converted 
directly to water. However, partial reduction of oxygen can and 
does occur in biological systems. Thus, the sequential reduction 
of oxygen along the univalent pathway leads to the generation 
of superoxide anion, hydrogen peroxide, hydroxyl radical, and 
water [15, 16]. Superoxide and hydrogen peroxide appear to be the 
primary generated species. These species may then play a role 
in the generation of additional and more reactive oxidants, 
including the highly reactive hydroxyl radical (or a related 
highly oxidizing species) in which iron salts play a catalytic role 
in a reaction. This reaction is commonly referred to as the metal 
catalyzed Haber-Weiss reaction [15]: 
Fe3+ + O₂→ Fe2+ + O₂ 
Fe2+ + H₂O₂ → Fe3+ OH + OH- 
O2- + H₂O₂→ .OH + OH- 
Iron is the most abundant trace element in the body, and almost 
all iron occurs bound to proteins. Iron is a double-edged sword. 
In moderate quantities and leashed to protein, it is an essential 
element in all cell metabolism and growth, but it is toxic when 
unleashed [17]. 
Because of its ability to switch back and forth between ferrous 
and ferric oxidation states, iron is both a strong biological 
oxidant and reductant. Although the exact mechanism of iron-
induced diabetes is uncertain, it is likely, to be mediated by three 
Int J Clin and Biomed Res. 2015;1(3): 30-37 Page 34 
 
 
Serum Ferritin and HbA1c levels in Type 2 Diabetes Mellitus                                                                                                                                                 Padmaja P et al. 
key mechanisms: Insulin deficiency, insulin resistance and 
hepatic dysfunction [18]. 
The central importance of iron in the pathophysiology of disease 
is derived from the ease with which iron is reversibly oxidized 
and reduced. This property, while essential for its metabolic 
functions, makes iron potentially hazardous because of its 
ability to participate in the generation of powerful oxidant 
species such as hydroxyl radical [15]. 
Free radical damage is produced primarily by the hydroxyl 
radical (OH). Most of the OH generated in vivo comes from 
iron-dependent reduction of H2O2. When ferrous iron reduces 
H2O to generate OH, it becomes ferric iron. Vitamin C (ascorbic 
acid) converts ferric iron back to ferrous iron, itself becoming 
oxidized ascorbic acid, thus allowing another cycle of .OH 
generation from renewed ferrous iron. 
Another endogenous source of catalytic free iron is the iron 
released when the heme ring is opened by hemeoxygenase[9]. 
The intracellular generation of apoferritin is a cytoprotective 
antioxidant stratagem of endothelial cells [19, 20], since serum 
ferritin is elevated in T2DM. 
Under normal conditions a quantitative relationship exists 
between the level of plasma ferritin and the amount of storage 
iron [8]. In conditions of iron overload there is generally an 
increase in the expression of intracellular L-subunit rich 
ferritins, paralleled by an increase in these ferritins in the plasma 
[21]. 
Ferritin is considered a positive acute phase protein and is 
upregulated intracellularly in many cell types, and 
extracellularly, in the plasma as a result of an increase in cellular 
secretion. An important role for ferritin during the acute phase 
response is to restrict the availability of iron by sequestration 
into the cavity of the ferritin protein shell. 
Oxygen radicals i.e., molecules containing unpaired electrons 
are generated in large amounts during infectious and 
inflammatory conditions [22]. They react with proteins, lipids and 
nucleic acids, resulting in degradation of the phagocytosed 
material in the confinements of the phagosome in the neutrophil 
and macrophage. 
However, large amounts of these toxic metabolites leak to the 
fluids and tissues in the area of the inflammatory reaction and 
by reacting with cellular constituents can result in substantial 
damage [23]. Iron, due to its role in Fenton-type chemistry, can 
result in exacerbation of oxygen radical production. 
In general, a reduction in the bio-availability of iron will offer 
protection against cell injury by hydroxyl radicals that are 
generated from neutrophil- and macrophage-derived 
superoxides [24]. Iron sequestration by cells in the zone of 
inflammation may therefore provide protection against the free 
radical assault [25]. This role of host cell protection against an 
increase in the free radical onslaught is consistent with 
observations that a reduction in ferritin sensitizes cells to pro-
oxidant cytotoxicity, and that overexpression of ferritin reduces 
reactive oxidant species (ROS) in cells challenged by oxidants 
and by implication reduces the oxidative toxicity [8]. 
The role of iron in the pathogenesis of diabetes is suggested by 
an increased incidence of type 2 diabetes in diverse causes of 
iron overload and reversal or improvement in diabetes 
(glycemic control) with a reduction in iron load achieved using 
either phlebotomy or iron chelation therapy [18].The importance 
of protein glycation is well known in the pathogenesis of 
diabetic vascular complications. Transition metals also play a 
role in protein glycation induced by hyperglycemia. It has been 
shown that glycated proteins have a substantial affinity for the 
transition metals, and the bound metal retains redox activity and 
participates in catalytic oxidation. Thus, should similar 
glycochelates form in vivo, reactions mediated by the chelates 
could be involved in the vascular complications of diabetes [26]. 
Different theories regarding the role of ferritin in DM have been 
suggested. Ferritin has been referred as a marker for insulin 
resistance possibly due to iron deposition in the liver leading to 
hepatic insulin resistance and increased hepatic glucose 
production [10, 27]. Others has determined ferritin just as a marker 
of pancreatic inflammation, while pancreatic damage due to 
some degree of subclinical hemochromatosis has been 
considered in some cases of diabetes [12]. 
Two large epidemiological studies reported a strong association 
between elevated serum ferritin concentration and increased risk 
for diabetes [28, 29]. Recently this was also noted in two separate 
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studies by F. Sharifi et al in impaired glucose tolerance (IGT) 
and type2 DM [12]. In this study a statistically significant increase 
in FPG, HbA1c and serum ferritin levels were observed in type 
2 DM compared to normal healthy controls. In the study by F. 
Sharifi et al [12] no significant difference was observed between 
normal controls and diabetics regarding age and haemoglobin, 
no significant correlation between serum ferritin, blood sugar or 
HbA1c (r= 0.23). A study by Jose- Manuel Fernandez [27] 
reported a correlation (r=0.44) between serum ferritin and basal 
serum glucose and no correlation with age and HbA1c.In this 
study, too no significant variation of haemoglobin levels were 
observed between diabetics and healthy controls. In contrast to 
the above studies a low to moderate positive correlation of 
serum ferritin with age and FPG and high positive correlation 
with HbA1c were noted in both genders. 
CONCLUSION 
Increased levels of serum ferritin in diabetic cases as compared 
to controls indicates that serum ferritin can be used as a marker 
of type2 DM. Higher positive correlation of serum ferritin with 
HbA1c shows that metabolic control or dysglycemia affects 
ferritin levels possibly due to inflammation or oxidative stress 
or a combination of the two as both mechanisms play an 
important role in pathogenesis of type 2 DM. 
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